The drug Aromex Alpha Pharma 25mg is a medication group of aromatase inhibitors that reduce estrogen in the body. This drug is approved in the United States and is used in the treatment of breast cancer.
In bodybuilding Aromex Alpha Pharma 25mg is applied on a steroid course to reduce aromatase effect (the conversion of testosterone to estrogen) when taking anabolic hormones.
Effects Aromex Alpha Pharma 25mg
Prevention of gynecomastia
The decreased production of estrogen (97%)
Increasing the level of anabolic hormones
Improving muscle definition muscle
Prevention of hypertension
Reduce estrogenic suppression of the axis hypothalamus-pituitary-testes
Dosage and course of treatment Aromex Alpha Pharma 25mg
For prophylaxis (in bodybuilding): 12.5 mg every other day.
For gynecomastia treatment: 25 mg every day until disappearance of symptoms (12.5 mg every other day).
Admission at the rate of steroids:
When using steroids with a short half-life (testosterone propionate, methandrostenolone): 10 days of the course to pass the test, estradiol, and take 12.5 mg Aromasin (Exemestane) a day. Then after 10 days again to be tested for estradiol and to adjust the dosage of Aromasin (Exemestane) according to their results.
When you use steroids with long esters (enanthate, Sustanon, cypionate): after 3-4 weeks of the course to be tested for estradiol and take 12,5 mg Aromasin (Exemestane) a day. Then after 10 days again to be tested for estradiol and to adjust the dosage of Aromasin (Exemestane) according to their results.
Like other aromatase inhibitors, the dosage can be adjusted subjectively. In case there is a depression, a drop in libido and erectile dysfunction, dosage should be reduced.
Exceeding the dosages and the abuse of aromatase inhibitors leads to excessive suppression of the production of estrogens and the following effects:
Inhibition of growth of muscle mass
The drop in libido
Increase of level of cholesterol
The decrease in bone strength
Side effects Agamah (Exemestane):
Increased risk of fractures (by 60%)
The formation of arterial and venous thrombi
Dryness of the mucous membranes of the urogenital area